testnews
Syndication, testnews »
Hard at work against the hardening of arteries |  |
|
Posted by sandiegobiotech May 16th, 2013 .
| |
| No Comments |
Sanford-Burnham researchers identified a potential drug target to prevent the hardening of arteries in patients with atherosclerosis. The gene Dkk1 encodes a protein that plays a key role in increasing the population of connective-tissue cells during wound repair, but prolonged Dkk1 signaling in cells lining blood vessels can lead to fibrosis and a stiffening of artery walls.
More...Syndication, testnews »
Hard at work against the hardening of arteries | |
|
Posted by sandiegobiotech May 16th, 2013 .
| |
| No Comments |
Sanford-Burnham researchers identified a potential drug target to prevent the hardening of arteries in patients with atherosclerosis. The gene Dkk1 encodes a protein that plays a key role in increasing the population of connective-tissue cells during wound repair, but prolonged Dkk1 signaling in cells lining blood vessels can lead to fibrosis and a stiffening of artery walls.
More...Syndication, testnews »
San Diego’s AnaptysBio Gets BioDefense Contract for Ricin Antibodies | |
|
Posted by sandiegobiotech May 16th, 2013 .
| |
| No Comments |
AnaptysBio says today the U.S. government has asked the San Diego biotech to produce antibodies that counter the deadly effects of ricin and would not require refrigeration, so batches of anti-ricin…
[[Click headline to continue reading.]]
More...Syndication, testnews »
Ambit Slices Price of IPO, Increases Number of Shares Offered | |
|
Posted by sandiegobiotech May 16th, 2013 .
| |
| No Comments |
San Diego’s Ambit Biosciences cut the share price of its planned IPO by nearly half yesterday, but still managed to raise about $65 million by increasing the number of shares in its debut offering….
[[Click headline to continue reading.]]
Syndication, testnews »
Ambit Biosciences Cuts IPO Price | |
|
Posted by sandiegobiotech May 16th, 2013 .
| |
| No Comments |
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!Ambit Biosciences Announces Pricing of Initial Public OfferingSAN DIEGO, May 16, 2013 /PRNewswire/ — Ambit Biosciences Corporation today announced the…
More...Syndication, testnews »
Halozyme Therapeutics, Inc. to Present New Data on PEGPH20 In Pancreatic Cancer at American Society of Clinical Oncology Annual Meeting | |
|
Posted by sandiegobiotech May 16th, 2013 .
| |
| No Comments |
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!SAN DIEGO, May 15, 2013 /PRNewswire/ — Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that clinical data…
More...Syndication, testnews »
Receptos to Deliver Scientific Presentations at About the Therapeutic Role of RPC1063 in Inflammatory Bowel Disease | |
|
Posted by sandiegobiotech May 16th, 2013 .
| |
| No Comments |
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!SAN DIEGO, May 15, 2013 (GLOBE NEWSWIRE) — Receptos (Nasdaq:RCPT) today announced that Company personnel will deliver three scientific poster presentations abou…
More...Syndication, testnews »
RuiYi (formerly Anaphore) and Collaborate on Development in China of RYI-008, a Novel Therapeutic for Autoimmune Diseases and Cancer | |
|
Posted by sandiegobiotech May 16th, 2013 .
| |
| No Comments |
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!LA JOLLA, Calif. and SHANGHAI, May 16, 2013 /PRNewswire/ — RuiYi Inc. announced today…
More...Syndication, testnews »
Santarus Inc. Announces Exercise in Full of Option to Purchase Additional Shares and Completion of Secondary Common Stock Offering | |
|
Posted by sandiegobiotech May 16th, 2013 .
| |
| No Comments |
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!SAN DIEGO–(BUSINESS WIRE)–Santarus, Inc. (NASDAQ: SNTS) today announced the completion of a secondary underwritten public offering of 4,887,500 shares of its c…
More...Syndication, testnews »
Illumina, Inc. Launches BaseSpace® Apps | |
|
Posted by sandiegobiotech May 16th, 2013 .
| |
| No Comments |
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ:ILMN) today announced the full commercial availability of BaseSpace, the Companys genomics cloud computing and…
More...
